Finding Relief from Opioid-Induced Constipation: Emerging Therapies for Individualized Management

Sponsored by an educational grant from Salix Pharmaceuticals, Inc., A Division of Valeant Pharmaceuticals North America LLC and Consultant, a registered trademark of HMP Communications

Saturday, September 9

Start Time

End Time

Gracia 1
Level 3

Learning Objectives

  • Recognize the prevalence, burden, and barriers to care faced by chronic pain patients with OIC
  • Discuss the latest criteria for the screening and diagnosis of OIC in patients with chronic pain managed by opioids
  • Evaluate the full OIC treatment armamentarium--including emerging targeted therapies--in terms of mechanism of action, safety, and efficacy
  • Develop tailored treatment plans that apply the latest consensus recommendations and prescription therapies to effectively manage OIC

Jeffrey A. Gudin, MD

Registration Website

Contact Name
MaryEllen Fama

Contact Phone
(609) 630-6205

Contact email


Related Content